IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, announced two new Connecticut infusion centers in the greater New Haven and Norwalk communities. The company says it is currently accepting patients at its Glastonbury and Orange centers, with the Norwalk location opening this summer.
Further reading: How the Pandemic Has Impacted Infusion Therapy
IVX Health’s clinical model is designed to provide ongoing biologic infusion and injection therapy for immunocompromised patients. Each center is staffed with a team of nurse practitioners and registered nurses, overseen by physician specialists serving as local medical directors. Every patient is provided a modern, private, and comfortable infusion suite—equipped with the same safety protocols as a traditional hospital infusion setting.
The company says it also provides a 1:3 nurse-to-patient ratio to ensure high-frequency, personalized encounters at each care visit.
“IVX Health partners directly with health systems and provider offices to coordinate care and facilitate prior authorization, benefits eligibility, and copay assistance support on behalf of each patient,” says Shazmin Bhanji, senior vice president of sales with IVX Health. “IVX Health’s commitment to world-class service and clinical excellence – for both patients and referring providers – is why gastroenterologists, rheumatologists, neurologists, and other physician specialists in Connecticut and across the country choose IVX Health as their preferred site of care for their biologic infusion and injection patients.”
Additionally, all of its locations offer patient-focused amenities such as guaranteed private suites, large leather recliners, flat screen TVs with streaming options, and more, the company says.
